

BACKGROUND:
Pakistan Rural Workers Social Welfare Organization (PRWSWO), a non-profit making non-governmental organization founded in 1997 by a group of community workers interested in the improvement of the standard of life of the disadvantage sections of the society particularly rural masses, through a variety of socio economic services by adopting multi-disciplinary approaches in the different social sectors.
PURPOSE:
The main purpose of PRWSWO is to improve the socio-economic conditions of disadvantaged, vulnerable & poverty stricken rural communities along with marginalized and indigenous population by adopting multi-dimensional approaches and meaningful community based initiatives and demand driven interventions.
VISION:
To build communities where people can lead their lives with dignity, honour and without any discrimination based on class, race, religion or language.
MISSION:
PRWSWO mission is to create a society where marginalized and vulnerable communities are socially, economically & politically empowered through their active participation
GOAL:
To strive for existence of a balanced and peaceful society having protection & promotion of basic human rights, dignity, honor, self respect, harmony, inter faith and social justice for all regardless of caste, color, race age, creed, gender, social status, religion & language etc.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close